The global autoimmune disease therapeutics market is anticipated to expand steadily from 2025 to 2035, driven by increasing cases of rheumatoid arthritis, psoriasis, and inflammatory bowel disease.

Aggressive treatment for patients who look like they may soon develop rheumatoid arthritis (RA) appears very effective for ...

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved biosimilars starting next month for members of its commercial health ...

Some Michigan hospitals are marking up prescription drug prices by 800% above what they they pay manufacturers, according to a new report from the Michigan Health Purchasers Coalition.

In this article, we are going to take a look at where Organon & Co. (NYSE:OGN) stands against other best-performing stocks. Organon rallied for a third consecutive day on Thursday, jumping 4.26 ...

DEAR DR. ROACH: I’m a 67-year-old healthy male, but I do take Humira for rheumatoid arthritis (RA). It does a wonderful job for me with no side effects. It does such a good job that I can ...

Dear Dr. Roach: I’m a 67-year-old healthy male, but I do take Humira for rheumatoid arthritis (RA). It does a wonderful job for me with no side effects. It does such a good job that I can ...

(Reuters) - UnitedHealth Group said on Tuesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1 ...

(Reuters) - Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less ...